This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Intellectual property waiver for Covid-19 vaccines opposed by US House Judiciary Republican members

( May 4, 2021, 19:23 GMT | Official Statement) -- MLex Summary: A request from India, South Africa and other nations to temporarily waive certain parts of the Trade-Related Aspects of Intellectual Property Rights for Covid-19 vaccines is "extraordinarily broad" and "unnecessary to accomplish the goal of giving as many people as possible access to vaccines and treatments for the virus, including in developing countries," Republican members of the House Judiciary Committee said in a letter to US Trade Representative Katherine Tai. "Rather, the waiver would undermine the very innovation that has led to the record-breaking rapid development of COVID-19 vaccines already saving lives around the world, and it would not meaningfully improve vaccine availability," they said. Statement and letter follow below:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections